eradication therapy in patients with immune thrombocytopenic purpura | ||||
| Journal of Current Medical Research and Practice | ||||
| Volume 5, Issue 1, January 2020, Page 32-35 PDF (369.65 K) | ||||
| DOI: 10.4103/JCMRP.JCMRP_154_19 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Nabila Faiek; Safinaz Hussein; Reham Badr | ||||
| Abstract | ||||
| Objective: The aim was to determine the frequency of infection in patients with immune thrombocytopenic purpura (ITP) and to detect the effect of its eradication therapy on platelet count response in -positive patients. Patients and methods: stool antigen enzyme immunoassay test was done for 54 patients with ITP. -positive patients received standard triple therapy for 2 weeks. Platelet count response to eradication therapy was evaluated 2 and 3 months after the treatment. Results: infection was positive in 38 (70.4%) patients with ITP. Eradication of was achieved in 30 (78.9%) patients (responder group). There were statistically significant increases in platelet count (among the responder group) after eradication therapy at 2 and 3 months ( < 0.05). Conclusion: Eradication of infection in patients with ITP is associated with significant increase in platelet counts. | ||||
| Keywords | ||||
| eradication; Immune thrombocytopenic purpura | ||||
|
Statistics Article View: 55 PDF Download: 40 |
||||
